Biova, producer of the only eggshell membrane ingredients to be approved by EFSA, will be presenting new clinical data in conjunction with their European distribution partner, Disproquima at VitaFoods this year.
A new clinical study on the benefits of BiovaFlex for joint health was completed last year. Biova will be holding one-on-one meetings throughout the VitaFoods tradeshow for attendees who want more information on the results of the study. Amanda Orloske, Sr. Director of International Sales said, “Significant results were observed in those study participants who used BiovaFlex and we are excited to share those results with new potential partners.”
You can find the official EFSA announcement on Novel Foods and information about Biova’s exclusivity here.
Attendees who would like to hear more about the new study are invited to contact either Biova (Info@Biova.com) or Disproquima (Info@Disproquima.com) to schedule a meeting.
